Crestor (rosuvastatin) is a popular cholesterol-lowering drug in the statin class that has been linked to type-2 diabetes. Although some studies have found that Crestor may increase the risk of diabetes by 27%, many victims have only recently learned about the danger.
Crestor and Type-2 Diabetes
Crestor (rosuvastatin) has been linked to an 18% increased risk of type-2 diabetes compared to older statins, such as Pravachol (pravastatin), which appears to reduce the risk of diabetes. This conclusion was based on a population-based study of 1.5 million people, including 500,000 on statins, and it was published in the British Medical Journal in May 2013.
The U.S. Food and Drug Administration (FDA) has also warned that cholesterol-lowering statins could increase the risk of diabetes. The FDA cited data from numerous studies, including the JUPITER clinical trial, in which Crestor was linked to a 27% increased risk of diabetes.
About Class Actions
Class actions are a useful type of lawsuit when a lot of people have very similar legal claims against the same defendant — especially when it would be too expensive for one person to fight alone. By joining together, many people use their collective bargaining power to fight for a settlement or jury award on behalf of the entire group. If compensation is awarded, members of the class action share it evenly.